Last reviewed · How we verify

NCT04160663

Arterial Stiffness and Atrial Fibrillation

Terminated NA Last updated 17 January 2023
What this trial tests

NA trial testing Carotid Ultrasound in Atrial Fibrillation in 15 participants. Terminated before completion.

Timeline
29 October 2019
Primary endpoint
5 October 2020
5 October 2020

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment15
Start date29 October 2019
Primary completion5 October 2020
Estimated completion5 October 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 95, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers are trying to determine whether arterial stiffness detected by ultrasound can predict outcomes in the development and recurrence of atrial fibrillation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Carotid Ultrasound

Trials testing the same drug.

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04160663.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing